The human organoids market size is USD 1.8 Bn in 2026.
The human organoids market is projected to grow at a CAGR of 5% by 2033.
The human organoids market growth drivers include rising adoption in drug discovery, increasing use in personalized medicine, and expanding applications in regenerative medicine.
North America is a dominating region for the human organoids market.
Thermo Fisher Scientific, Corning, Emulate, InSphero, and MIMETAS are some leading industry players in the human organoids market.